Insider Trading & Ownership - Kastenmayer James Paul

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kastenmayer James Paul

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-01-25
8:38 pm
N/A
N/A
ArriVent Biopharma Inc.AVBPKastenmayer James Paul
General Counsel
0$0106,004
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:24 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
General Counsel
500,000$0500,000
(Direct)
View
2022-08-23
Option Award
2022-08-25
7:39 pm
N/A
2032-08-22
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
Interim CEO & General Counsel
130,000$0130,000
(Direct)
View

Ownership
2022-08-25
7:37 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
Interim CEO & General Counsel
0$0219,000
(Direct)
View
2021-03-15
Disposition
2021-03-15
09:16 am
N/A
2030-01-13
Viela Bio Inc.VIEKastenmayer James Paul
General Counsel
50,000$00
(Direct)
View
2020-01-14
Option Award
2020-01-15
4:40 pm
N/A
2030-01-13
Viela Bio Inc.VIEKastenmayer James Paul
General Counsel
50,000$050,000
(Direct)
View